OGS Names Daniel McBride and Meng Meng Xu to Board of Directors
Monday, October 23 2023 | 13 h 23 min | News, Press Release
Optometry Giving Sight (OGS) has announced the addition of Daniel McBride, executive vice president and chief operating officer of CooperCompanies, and Meng Meng Xu, OD, MPH, FAAO, to its board of directors.
“We are thrilled to welcome two new board members who are so highly regarded in the industry and profession,” said Lois Schoenbrun, executive director, OGS. “Mr. McBride has shown remarkable support for our mission over the years in his roles at CooperVision and CooperCompanies. Meanwhile, the combination of Dr. Xu’s experience in clinical optometry and international public health programs will bring valuable insight to OGS and our partners.”
CooperVision is the largest donor in OGS history, with a total contribution of more than $4 million. The company is a global platinum sponsor of the organization and provides additional support through employee fundraising activities with a company match, and a consumer rebate donation program.
McBride has served as executive vice president and chief operating officer for CooperCompanies since 2013. He previously served as president of CooperVision from 2014 through 2021. His prior roles at CooperVision also include chief risk officer, general counsel, vice president, and senior counsel. Before joining CooperVision in 2005, McBride was an attorney with Latham & Watkins LLP. He holds a bachelor’s degree in finance from Santa Clara University and a juris doctor from Stanford Law School.
Dr. Xu is an associate professor of clinical optometry and the director of eyecare services at South Boston Community Health Center. She also serves as coordinator of international programs at the New England College of Optometry, a role she has held for 10 years. Dr. Xu earned a master’s degree in public health from Harvard University and her doctorate in optometry from the University of Montreal.
Click HERE for the full press release.
For more related articles on Optik NOW, click HERE.
